Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes
-
García Loza, Iván (Institut de Recerca Sant Pau)
;
Perna-Barrull, David (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aguilera, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Almenara-Fuentes, Lidia (Ahead Therapeutics SL) ;
Gómez Muñoz, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Greco, Daniela (Ahead Therapeutics SL) ;
Vila, María (Ahead Therapeutics SL) ;
Salvado, Miriam (Ahead Therapeutics SL) ;
Mancera Arteu, Montserrat (Ahead Therapeutics SL) ;
Olszowy, Michael W. (Sartorius Stedim North America. Inc.) ;
Petriz, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Dalmases, Martí (Ahead Therapeutics SL) ;
Rodriguez-Vidal, Sílvia (Ahead Therapeutics SL) ;
Barneda Zahonero, Bruna (Ahead Therapeutics SL) ;
Vives Pi, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona